<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on 21/05/2026 at 21:36 by All in One SEO v4.9.7.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://medicaldevices.fr/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Medicaldevices.fr</title>
		<link><![CDATA[https://medicaldevices.fr]]></link>
		<description><![CDATA[Medicaldevices.fr]]></description>
		<lastBuildDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://medicaldevices.fr/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://medicaldevices.fr/notified-bodies-under-pressure-for-medical-devices-ce-marking/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/notified-bodies-under-pressure-for-medical-devices-ce-marking/]]></link>
			<title>Notified body under pressure  to deliver Medical Devices CE Marking</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://medicaldevices.fr/namix-ra-syringe-recall-escalate-to-class-i-after-fda-intervention/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/namix-ra-syringe-recall-escalate-to-class-i-after-fda-intervention/]]></link>
			<title>Namix RA syringe recall escalate to Class I after FDA Intervention.</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://medicaldevices.fr/europe-finally-gets-its-own-breakthrough-program-for-medical-devices/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/europe-finally-gets-its-own-breakthrough-program-for-medical-devices/]]></link>
			<title>Europe finally gets its own Breakthrough program for medical devices</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://medicaldevices.fr/embecta-acquires-owen-mumford-in-150m-deal-betting-big-on-the-future-of-drug-delivery/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/embecta-acquires-owen-mumford-in-150m-deal-betting-big-on-the-future-of-drug-delivery/]]></link>
			<title>Embecta Acquires Owen Mumford in £150M Deal, Betting Big on the Future of Drug Delivery</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://medicaldevices.fr/team-nb-2025-sector-survey-growth-slowdown-and-workforce-pressures-among-notified-bodies/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/team-nb-2025-sector-survey-growth-slowdown-and-workforce-pressures-among-notified-bodies/]]></link>
			<title>Team-NB 2025 Sector Survey: Growth Slowdown and Workforce Pressures Among Notified Bodies</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://medicaldevices.fr/medtronic-to-acquire-spr-therapeutics-for-650m-strengthening-its-chronic-pain-portfolio/]]></guid>
			<link><![CDATA[https://medicaldevices.fr/medtronic-to-acquire-spr-therapeutics-for-650m-strengthening-its-chronic-pain-portfolio/]]></link>
			<title>Medtronic to acquire SPR Therapeutics for $650M, strengthening its chronic pain portfolio</title>
			<pubDate><![CDATA[Wed, 20 May 2026 15:28:29 +0000]]></pubDate>
		</item>
				</channel>
</rss>
